Search results for: 'pipelin'

Therapeutic medical devices play a significant role in the long-term treatment of chronic conditions such as cancer and neurological diseases. Non-invasive therapeutic medical devices capable of offering home-based treatment provide high patient comfort and adherence to the prescribed therapy. With the changing preference of the patients, the medic...

This growth opportunity-technology (GO-TE) study identifies and analyzes some of the key developments in diagnostic medical devices across major therapeutic areas such as cardiology, neurology, and oncology. The research highlights the breakthrough diagnostic medical device technologies that are likely to be approved in the next 2-3 years. These pr...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

The global economy is facing what is likely to be the worst economic disruption since World War II. As the COVID-19 pandemic rapidly spreads globally, the concurrent economic fallout of this health crisis is expected to be grave. Frost & Sullivan has analyzed the scale of impact on global GDP growth and other macroeconomic elements through scenario...

16 Apr 2020  |  Global  |  Market Research

Post-pandemic Growth Opportunity Analysis of the Marketing Automation Solutions Market

Assessing Growth Opportunities and Growth Pipelines in Light of the COVID-19 Pandemic

Infographics

×

Marketing automation solutions (MAS) constitute the following four functions: campaign management, sales enablement, lead management, and data and analytics. MAS differentiate from marketing process automation solutions, customer relationship management, digital asset management, and email marketing software. MAS serve the small- and medium-sized b...

Like other economies, countries in the GCC have been rendered vulnerable by the COVID-19 pandemic. Wholesale and retail trade, transportation and storage, and finance and insurance, which accounted for nearly 50% of Dubai’s gross domestic product (GDP) in 2018, have all been affected. In the oil and gas industry, plunging jet fuel demand and higher...

23 Oct 2020  |  Global  |  Market Research

Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026

Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities

Infographics

×

The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...

03 Dec 2020  |  Asia Pacific  |  Market Research

Rising Competitive Intensity in Indonesia’s Data Center Colocation Services Market

Increase in Adoption of Data-intensive Technologies to Boost the Growth Pipeline for Colocation Services

Infographics

×

Key Benefits

To increase their presence, hyperscale cloud service providers, such as Alibaba, Microsoft, and Amazon Web Services, along with the local cloud vendors, are expanding their infrastructure, operations, and availability across Indonesia. With the extensive penetration of Internet connectivity, as well as a keen focus on cybersecurity and data privacy...

29 Jun 2020  |  Global  |  Technology Research

Decoding Technological Advances in Biomanufacturing

Growing Viral Vector Contract Development Manufacturing Landscape

Infographics

×

The rise in gene therapies over the last few years has created a huge opportunity for viral vector Contract Research Development Organization (CMO/CDMO) to fill the gap of high demand and shortage of viral vectors. As of January 2020, the US Food and Drug Administration FDA has approved four gene therapies and claims to have over 900 therapies i...